73 related articles for article (PubMed ID: 20925531)
1. Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumonia.
Schouten M; van 't Veer C; van den Boogaard FE; Gerlitz B; Grinnell BW; Roelofs JJ; Levi M; van der Poll T
J Infect Dis; 2010 Nov; 202(10):1600-7. PubMed ID: 20925531
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia.
Schouten M; van 't Veer C; Roelofs JJ; Gerlitz B; Grinnell BW; Levi M; van der Poll T
Thromb Haemost; 2011 Dec; 106(6):1189-96. PubMed ID: 21901240
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.
van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA
Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia.
Wang E; Bergeron Y; Bergeron MG
J Antimicrob Chemother; 2005 May; 55(5):721-6. PubMed ID: 15772139
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia.
Rijneveld AW; Florquin S; Hartung T; Speelman P; van der Poll T
J Infect Dis; 2003 Jul; 188(2):282-5. PubMed ID: 12854084
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia.
Van Den Boogaard FE; Brands X; Schultz MJ; Levi M; Roelofs JJ; Van 't Veer C; Van Der Poll T
J Thromb Haemost; 2011 Jan; 9(1):122-32. PubMed ID: 21029363
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia.
Wang E; Simard M; Ouellet N; Bergeron Y; Beauchamp D; Bergeron MG
J Infect Dis; 2000 Oct; 182(4):1255-9. PubMed ID: 10979929
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C in a pregnant patient with severe sepsis.
Mahabeer N; Zwaal J
Hosp Med; 2005 Feb; 66(2):124. PubMed ID: 15739714
[No Abstract] [Full Text] [Related]
9. The cytoprotective effects of endogenous activated protein C reduce activation of coagulation during murine pneumococcal pneumonia and sepsis.
Schouten M; van 't Veer C; Poulussen N; Meijers JC; Levi M; Esmon CT; van der Poll T
Thromb Res; 2015 Mar; 135(3):537-43. PubMed ID: 25586194
[TBL] [Abstract][Full Text] [Related]
10. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
[TBL] [Abstract][Full Text] [Related]
11. [Exogenous activated protein C in severe sepsis].
Mamontova OA; Protsenko DN; Eliutin DV; Kirienko PN; Gel'fand BR
Anesteziol Reanimatol; 2005; (3):42-5. PubMed ID: 16076046
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 2 inhibition diminished acute lung injury in murine pneumococcal pneumonia.
Witzenrath M; Gutbier B; Schmeck B; Tenor H; Seybold J; Kuelzer R; Grentzmann G; Hatzelmann A; van Laak V; Tschernig T; Mitchell TJ; Schudt C; Rosseau S; Suttorp N; Schütte H
Crit Care Med; 2009 Feb; 37(2):584-90. PubMed ID: 19114892
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist transiently impairs antibacterial defense but not survival in murine pneumococcal pneumonia.
Rijneveld AW; Florquin S; Speelman P; Edwards CK; Dinarello CA; van der Poll T
Eur Cytokine Netw; 2003; 14(4):242-5. PubMed ID: 14715417
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal efficacy of ABI-0043, a novel rifamycin, in a murine pneumococcal pneumonia model.
Lee SY; Tessier PR; Murphy CK; Nicolau DP
J Antibiot (Tokyo); 2006 Dec; 59(12):804-7. PubMed ID: 17323649
[TBL] [Abstract][Full Text] [Related]
15. Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
Preheim LC; Olsen KM; Yue M; Snitily MU; Gentry-Nielsen MJ
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):103-11. PubMed ID: 15698715
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy?
Regnault V; Levy B
Crit Care; 2007; 11(1):103. PubMed ID: 17224039
[TBL] [Abstract][Full Text] [Related]
17. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
Witzenrath M; Schmeck B; Doehn JM; Tschernig T; Zahlten J; Loeffler JM; Zemlin M; Müller H; Gutbier B; Schütte H; Hippenstiel S; Fischetti VA; Suttorp N; Rosseau S
Crit Care Med; 2009 Feb; 37(2):642-9. PubMed ID: 19114881
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.
Tavares LP; Garcia CC; Vago JP; Queiroz-Junior CM; Galvão I; David BA; Rachid MA; Silva PM; Russo RC; Teixeira MM; Sousa LP
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):24-34. PubMed ID: 26677751
[TBL] [Abstract][Full Text] [Related]
19. [Activated protein C, coagulation, inflammation, and treatment of severe sepsis].
van Deventer SJ; Pajkrt D
Ned Tijdschr Geneeskd; 2001 Mar; 145(13):613-6. PubMed ID: 11305209
[TBL] [Abstract][Full Text] [Related]
20. [Activated proteine C].
Montravers P; Quintard H; Piednoir P
Ann Fr Anesth Reanim; 2006 Mar; 25(3):270-4. PubMed ID: 16387470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
